Seascape Capital Management Abb Vie Inc. Transaction History

Seascape Capital Management

$280 Million
Q3 2024

A detailed history of Seascape Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Seascape Capital Management holds 27,111 shares of ABBV stock, worth $4.47 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

27,111

Previous 27,776 2.39%

Holding current value

$4.47 Million

Previous $4.76 Million 12.38%

% of portfolio

1.91%

Previous 1.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $108,953 - $132,554	-665 Reduced 2.39%	27,111 $5.35 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $55,105 - $64,350	356 Added 1.3%	27,776 $4.76 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $100,366 - $114,358	-628 Reduced 2.24%	27,420 $4.99 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $86,412 - $97,321	628 Added 2.29%	28,048 $4.35 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $20,572 - $23,816	154 Added 0.56%	27,420 $4.09 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $26,899 - $33,474	-203 Reduced 0.74%	27,266 $3.67 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $345,907 - $398,363	-2,392 Reduced 8.01%	27,469 $4.38 Million
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $79,113 - $94,877	-572 Reduced 1.88%	29,861 $4.83 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $239,699 - $274,918	1,786 Added 6.23%	30,433 $4.08 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $10,871 - $13,821	79 Added 0.28%	28,647 $4.39 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $40,253 - $49,943	-305 Reduced 1.06%	28,568 $4.63 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $72,944 - $92,296	679 Added 2.41%	28,873 $3.91 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $278,129 - $315,718	2,614 Added 10.22%	28,194 $3.04 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $42,504 - $47,352	-404 Reduced 1.55%	25,580 $2.77 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $42,504 - $47,352	404 Added 1.58%	25,984 $2.93 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $2,250 - $2,477	22 Added 0.09%	25,580 $2.77 Million
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $98,439 - $132,903	1,223 Added 5.03%	25,558 $2.74 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $7,474 - $8,772	-87 Reduced 0.36%	24,335 $2.13 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $121,060 - $161,997	-1,650 Reduced 6.33%	24,422 $2.4 Million
Q1 2020 May 28, 2020	BUY	$64.5 - $97.79 $20,575 - $31,195	319 Added 1.24%	26,072 $1.99 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $1.86 Million - $2.32 Million	25,753 New	25,753 $2.28 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.

Account

Seascape Capital Management Abb Vie Inc. Transaction History